Skip to content
Peptide research

Suprefort

Also known as Pancreas Bioregulator
Category
Bioregulators
Administration routes
Oral
Regulatory status
Not FDA-approved

What it is

Suprefort is a bioregulator peptide from pancreatic tissue, marketed to support pancreatic function in aging. Its best claim, glucose stabilization in early diabetes, rests on weak human data; digestive claims have limited observational support, while normalization of pancreatic function remains unproven. Main risks are a low chance of allergic reaction (bovine origin) and interaction with diabetes medications. It is not FDA-approved, and available products are unregulated.

Read Full record

Studied uses & evidence

Studied uses(3)

  • Improved digestive function in chronic pancreatitis

    Low

    A small 12-patient Khavinson Institute trial found modest enzyme gains; not peer-reviewed or independently confirmed.

  • Glucose level stabilization in latent type 2 diabetes

    Low

    A small, unpublished institute study found glucose improvement in latent type 2 diabetics taking Suprefort.

  • Normalization of pancreatic exocrine and endocrine function

    Low

    One small open-label Khavinson trial found eased pancreatitis symptoms and a glucose-trend improvement.

Evidence limits

Evidence Level
Very Limited Evidence

One formal clinical study from the Khavinson Institute tested Suprefort in 34 patients over 15 days. Results were modest but positive for both pancreatitis and diabetes subgroups. The study was open-label, single-center, and small. No independent replication exists.

Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)

Cautions & risk summary

General cautions

  • Pregnancy or breastfeeding

    Absolute

    No human reproductive safety data exists for this peptide. Effects on fetal development are unknown.

  • Children under 18

    Absolute

    No pediatric safety data. Not recommended for use in minors.

  • Known hypersensitivity

    Absolute

    Discontinue immediately if allergic reaction occurs (rash, swelling, difficulty breathing).

Risk summary(2)

Risks = level of concern: High · Moderate · Low · Theoretical

  • Allergic reaction to bovine pancreas-derived peptides

    Low
  • Potential interaction with diabetes medications

    Moderate
Safety & interactions in Full record

Further reading

Read Full record

This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer

Compiled from published research indexed through March 2026.